A detailed history of Quantbot Technologies LP transactions in Nkarta, Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 2 shares of NKTX stock, worth $5. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Holding current value
$5
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.52 - $8.0 $9 - $16
2 New
2 $0
Q3 2023

Nov 07, 2023

BUY
$1.39 - $2.29 $3,335 - $5,496
2,400 Added 160.0%
3,900 $5,000
Q2 2023

Aug 08, 2023

BUY
$2.19 - $5.17 $3,285 - $7,755
1,500 New
1,500 $3,000
Q4 2022

Feb 13, 2023

BUY
$5.14 - $14.35 $62,929 - $175,687
12,243 New
12,243 $73,000
Q2 2022

Aug 09, 2022

SELL
$7.77 - $19.44 $24,864 - $62,208
-3,200 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$8.66 - $14.99 $7,794 - $13,491
900 Added 39.13%
3,200 $36,000
Q4 2021

Feb 11, 2022

BUY
$12.79 - $26.88 $29,416 - $61,824
2,300 New
2,300 $35,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $131M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.